ARCH BIOPARTNERS INC (ARCH.CA) Stock Analyst Earnings Estimates
TSX-V:ARCH - TSX Venture Exchange - CA03938C1041 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 964.7K -75.18% | 1.984M 105.62% | 2.122M 6.97% | 2.02M -4.80% | -100.00% | 85.703M | 181.73M 112.05% | 290.15M 59.66% | ||
| EBITDA YoY % growth | N/A | N/A 51.22% | N/A -25.00% | -12.12M -140.00% | -16.521M -36.31% | -17.037M -3.12% | 64.225M 476.97% | 155.09M 141.48% | 256.9M 65.65% | |
| EBIT YoY % growth | -1.08M -21.14% | -2.996M -177.43% | -3.558M -18.74% | -13.383M -276.16% | -11.979M 10.49% | -2.604M 78.26% | 64.019M 2,558.33% | 154.88M 141.93% | 256.08M 65.34% | |
| Operating Margin | -111.95% | -151.05% | -167.67% | -662.50% | N/A | N/A | 74.70% | 85.23% | 88.26% | |
| EPS YoY % growth | N/A | -0.05 -71.62% | N/A -35.96% | -0.07 | -0.16 -131.43% | -0.04 75.00% | N/A | N/A | N/A |
All data in CAD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 | -0.02 -12.22% | -0.02 -44.29% | -0.02 -1.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.02 -500.00% | -0.02 | 0.00 | 0.99% |
| Q3 2024 Q2Q % growth | -0.01 -100.00% | -0.02 | 0.01 | 30.69% |
| Q2 2024 Q2Q % growth | -0.02 -20.00% | -0.02 | 0.00 | 10.89% |
| Q1 2024 Q2Q % growth | 42.29% | -0.02 | % | |
| Q4 2023 Q2Q % growth | 0.01 150.00% | -0.02 | 0.03 | 124.75% |
| Q3 2023 Q2Q % growth | -0.01 | -0.02 | 0.01 | 65.35% |
| Q2 2023 Q2Q % growth | -0.02 | -0.02 | 0.01 | 25.74% |
| Q1 2023 Q2Q % growth | -0.04 | -0.01 | -0.02 | -246.53% |
| Q4 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | 2.184M -13.71% | 2.184M | % | |
| Q1 2024 Q2Q % growth | 298.2K -31.40% | 298.2K | % | |
| Q4 2023 Q2Q % growth | 1.984M 105.62% | 1.984M | % | |
| Q2 2023 Q2Q % growth | 2.531M 125.32% | 2.531M | % | |
| Q1 2023 Q2Q % growth | 434.7K -0.05% | 434.7K | % | |
| Q4 2022 Q2Q % growth | 964.7K -48.37% | 964.7K | % | |
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | 1.124M 5,224.64% | % | ||
| Q4 2021 Q2Q % growth | 1.869M 2,651.84% | % | ||
| Q3 2021 Q2Q % growth | 1.997M 6,646.96% | % | ||
| Q2 2021 Q2Q % growth | 21.1K -28.72% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 67.9K 5.43% | % | ||
| Q3 2020 Q2Q % growth | 29.6K 0.34% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |